SCHEMBL4454097

SCHEMBL4454097

CCCCc1ccc(C=Cc2ccc(C=O)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
HPGD P15428 4/20 0.47
HSD17B10 Q99714 2/20 0.47
SPHK1 Q9NYA1 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
LMNA P02545 2/20 0.46
THRA P10827 1/20 0.46
THRB P10828 1/20 0.46
MAPT P10636 1/20 0.46
CA2 P00918 2/20 0.46
GRIN2D O15399 1/20 0.45
GRIN3B O60391 1/20 0.45
GRIN1 Q05586 1/20 0.45
GRIN2A Q12879 1/20 0.45
GRIN2B Q13224 1/20 0.45
GRIN2C Q14957 1/20 0.45
GRIN3A Q8TCU5 1/20 0.45
CYP3A4 P08684 2/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL219423 0.94 ALDH1A1 (0.52) ALDH1A1HPGDHSD17B10SMN1; SMN2LMNA
SCHEMBL13863197 0.93 ESR1 (0.52) ALDH1A1HSD17B10SPHK1LMNATHRA
SCHEMBL416529 0.89 RARB (0.56) ALDH1A1HPGDHSD17B10SMN1; SMN2LMNA
SCHEMBL847304 0.88 ALDH1A1 (0.53) ALDH1A1HPGDHSD17B10SMN1; SMN2LMNA
SCHEMBL6067892 0.86 ESR1 (0.57) ALDH1A1HSD17B10LMNATHRATHRB
SCHEMBL2120077 0.86 ESR1 (0.57) ALDH1A1HSD17B10LMNATHRATHRB
SCHEMBL11811560 0.86 ESR1 (0.57) ALDH1A1HSD17B10LMNATHRATHRB
SCHEMBL20594193 0.86 ESR1 (0.57) ALDH1A1HSD17B10LMNATHRATHRB
SCHEMBL1872841 0.86 ESR1 (0.57) ALDH1A1HSD17B10LMNATHRATHRB
SCHEMBL9026740 0.86 ESR1 (0.57) ALDH1A1HSD17B10LMNATHRATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7589232-B2 Alkynyl aryl carboxamides LABORATORIES SERONO S.A. (CH) 2009-09-15 US disclosed
US-20070105913-A1 Alkynyl aryl carboxamides APPLIED RESEARCH SYSTEMS ARS HOLDINGS N.V. (NL) 2007-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070105913-A1 Alkynyl aryl carboxamides ECHS1, IRS1, HCCS ALDH1A1 1454/4885HPGD 2133/4885HSD17B10 80/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.